Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Geissler

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Leukemia|May 28, 2020
Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needsGiora Sharf, Celia Marin, Jennifer A Bradley, et al.
Frontiers in Pharmacology|November 5, 2025
Methodological study protocol for The European Atlas of clinical trials in cancer and haematologyMercè Cases, Rachel Giles, Tamás Ágh, et al.
Frontiers in Pharmacology|December 8, 2025
Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematologyMercè Cases, Rachel Giles, Tamás Ágh, et al.
Therapeutic Innovation & Regulatory Science|November 6, 2015
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for ActionAnton Hoos, James Anderson, Marc Boutin, et al.
Frontiers in Oncology|April 22, 2026
Correction: Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97)Sabine Felser, Maximilian Koeppel, Rea Kuehl, et al.
Frontiers in Oncology|April 8, 2026
Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97)Sabine Felser, Maximilian Koeppel, Rea Kuehl, et al.
Journal of Hematology & Oncology|December 19, 2024
Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE studyTimothy P Hughes, Giuseppe Saglio, Jan Geissler, et al.
Future Oncology (London, England)|June 11, 2025
Barriers and solutions for healthcare professionals to involve patients as partners in oncology research: project RISEEamonn T Rogers, Thomas G Bognanno, Thomas Perkins, et al.
Research Involvement and Engagement|November 7, 2024
Embedding patient engagement in the R&D process of a life sciences company through co-creation with a patient expert R&D board: a case studyEstelle Jobson, Marta Garcia, Danika Sharek, et al.
Trials|May 29, 2020
Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meetingKatharina M Lang, Kathryn L Harrison, Paula R Williamson, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Leukemia|May 28, 2020
Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needsGiora Sharf, Celia Marin, Jennifer A Bradley, et al.
Frontiers in Pharmacology|November 5, 2025
Methodological study protocol for The European Atlas of clinical trials in cancer and haematologyMercè Cases, Rachel Giles, Tamás Ágh, et al.
Frontiers in Pharmacology|December 8, 2025
Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematologyMercè Cases, Rachel Giles, Tamás Ágh, et al.
Therapeutic Innovation & Regulatory Science|November 6, 2015
Partnering With Patients in the Development and Lifecycle of Medicines: A Call for ActionAnton Hoos, James Anderson, Marc Boutin, et al.
Frontiers in Oncology|April 22, 2026
Correction: Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97)Sabine Felser, Maximilian Koeppel, Rea Kuehl, et al.
Frontiers in Oncology|April 8, 2026
Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97)Sabine Felser, Maximilian Koeppel, Rea Kuehl, et al.
Journal of Hematology & Oncology|December 19, 2024
Asciminib add-on to imatinib demonstrates sustained high rates of ongoing therapy and deep molecular responses with prolonged follow-up in the ASC4MORE studyTimothy P Hughes, Giuseppe Saglio, Jan Geissler, et al.
Future Oncology (London, England)|June 11, 2025
Barriers and solutions for healthcare professionals to involve patients as partners in oncology research: project RISEEamonn T Rogers, Thomas G Bognanno, Thomas Perkins, et al.
Research Involvement and Engagement|November 7, 2024
Embedding patient engagement in the R&D process of a life sciences company through co-creation with a patient expert R&D board: a case studyEstelle Jobson, Marta Garcia, Danika Sharek, et al.
Trials|May 29, 2020
Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meetingKatharina M Lang, Kathryn L Harrison, Paula R Williamson, et al.
Pageof 5